Tuberculosis Risk Stratification of Psoriatic Patients Before Anti-TNF-α Treatment

Tuberculosis Risk Stratification of Psoriatic Patients Before Anti-TNF-α Treatment

Psoriasis is a skin inflammatory condition for which significant progress has been made in its management by the use of targeted biological drugs. Detection of latent M. tuberculosis infection (LTBI) is mandatory before starting biotherapy that is associated with reactivation risk. Together with eva...

Full description

Bibliographic Details
Main Authors: Farida Benhadou, Violette Dirix, Fanny Domont, Fabienne Willaert, Anne Van Praet, Camille Locht, Françoise Mascart, Véronique Corbière
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-06-01
Series:Frontiers in Immunology
Subjects:
psoriasis
Tumor necrosis factor-α inhibitors
latent tuberculosis infection
tuberculin skin tests
interferon-γ-release assays
QuantiFERON
Online Access:https://www.frontiersin.org/articles/10.3389/fimmu.2021.672894/full

Internet

https://www.frontiersin.org/articles/10.3389/fimmu.2021.672894/full

Similar Items